Anpario (LON:ANP) Posts Quarterly Earnings Results

by · The Cerbat Gem

Anpario (LON:ANP – Get Free Report) announced its earnings results on Wednesday. The company reported GBX 22.45 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Anpario had a net margin of 14.31% and a return on equity of 16.88%.

Anpario Stock Down 2.5%

Shares of Anpario stock opened at GBX 467.88 on Thursday. Anpario has a 1 year low of GBX 391.11 and a 1 year high of GBX 580. The business has a 50-day moving average of GBX 531.50 and a two-hundred day moving average of GBX 516.75. The company has a market capitalization of £76.20 million, a P/E ratio of 12.33 and a beta of 1.08. The company has a debt-to-equity ratio of 0.60, a current ratio of 4.50 and a quick ratio of 5.16.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Shore Capital Group restated a “house stock” rating on shares of Anpario in a report on Monday, August 17th. Canaccord Genuity Group reiterated a “buy” rating and set a GBX 570 price target on shares of Anpario in a research report on Friday, June 26th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, Anpario has an average rating of “Buy” and a consensus price target of GBX 570.

View Our Latest Analysis on Anpario

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Featured Stories